The goal of this predoctoral training program is to provide students with the intellectual and technical skills required to solve important and complex biological problems that can be most effectively addressed by studies at the chemistry-biology interface, and to create a group of graduating chemists and biologists who can effectively communicate and function successfully in multidisciplinary teams. The focus of the training program is mechanistic chemistry of biomolecules, which is a theme that is of special interest to a significant population of faculty and students on campus, and provides an excellent model system for the application of chemical tools to solve important biological problems. The Program involves 29 participating faculty from The Wistar Institute and two separate Schools within the University of Pennsylvania, The School of Medicine and The School of Arts and Sciences. Participating students come primarily from two graduate groups that span institution and school boundaries, the Graduate Group in Chemistry and the Graduate Group in Biochemistry and Biophysics. Students typically join the program when they matriculate and a subset of these students is funded on the training grant after they have chosen a thesis laboratory at the beginning of their second year. We request funding for 9 students. To insure cross-fertilization between the chemistry and biology students, those in the OBI program carry out dissertation research at the chemistry-biology interface with a CBI trainer and also participate in the following activities: (1) A course curriculum that crosses the chemistry- biology academic boundary and centers around the mechanistic chemistry of biomolecules, (2) A student run speaker-invited thrice-yearly Chemical Biophysics mini-symposia seminar series centered around the chemistry-biology interface, (3) A monthly luncheon in which CBI students and faculty informally discuss their research among themselves, and (4) An annual Chemistry-Biology Interface Retreat in which students interact and present their work to each other and other trainees and trainers. The program also has effective mechanisms in place for instruction in the responsible conduct of research and the recruitment of underrepresented minorities, the disadvantaged and the disabled. A training committee is comprised of roughly equal faculty representation from the three participating programs and trainee representatives, which meets annually. The training committee is responsible for selecting students for training slot positions, insures equitable distribution of students, encourages application from underrepresented minorities, the disadvantaged and disabled and administers other functions of the grant.

Public Health Relevance

Research at the Chemistry-Biology Interface forms a cornerstone for understanding the detailed molecular mechanisms of molecules that mediate cellular functions during health as well as disease when certain molecules, such as proteins, have aberrant function. Once these aberrant protein activities are understood at the molecular level, research at the Chemistry-Biology Interface can lead to the development of therapeutic agents, such as drugs, to treat diseases like cancer, cardiovascular abnormalities and metabolic disorders.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Fabian, Miles
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wistar Institute
United States
Zip Code
Marques, Bryan S; Nucci, Nathaniel V; Dodevski, Igor et al. (2014) Measurement and control of pH in the aqueous interior of reverse micelles. J Phys Chem B 118:2020-31
Jackrel, Meredith E; DeSantis, Morgan E; Martinez, Bryan A et al. (2014) Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156:170-82
Barros, Stephanie A; Chenoweth, David M (2014) Recognition of nucleic acid junctions using triptycene-based molecules. Angew Chem Int Ed Engl 53:13746-50
Malecka, Kimberly A; Fera, Daniela; Schultz, David C et al. (2014) Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem Biol 9:1603-12
Desantis, Morgan E; Sweeny, Elizabeth A; Snead, David et al. (2014) Conserved distal loop residues in the Hsp104 and ClpB middle domain contact nucleotide-binding domain 2 and enable Hsp70-dependent protein disaggregation. J Biol Chem 289:848-67
Liszczak, Glen; Goldberg, Jacob M; Foyn, Havard et al. (2013) Molecular basis for N-terminal acetylation by the heterodimeric NatA complex. Nat Struct Mol Biol 20:1098-105
Podlesny, Erin E; Kozlowski, Marisa C (2013) Divergent approach to the bisanthraquinone natural products: total synthesis of (S)-bisoranjidiol and derivatives from binaphtho-para-quinones. J Org Chem 78:466-76
Liszczak, Glen; Marmorstein, Ronen (2013) Implications for the evolution of eukaryotic amino-terminal acetyltransferase (NAT) enzymes from the structure of an archaeal ortholog. Proc Natl Acad Sci U S A 110:14652-7
Emerson, Daniel J; Weiser, Brian P; Psonis, John et al. (2013) Direct modulation of microtubule stability contributes to anthracene general anesthesia. J Am Chem Soc 135:5389-98
Podlesny, Erin E; Kozlowski, Marisa C (2012) Enantioselective total synthesis of (S)-bisoranjidiol, an axially chiral bisanthraquinone. Org Lett 14:1408-11

Showing the most recent 10 out of 21 publications